Investing Ideas
/
Swiss Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Swiss Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

17 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
BANB Bachem Holding	CHF 58.05	2.7%	-13.5%	CHF 4.4b	CHF 76.00	PE38.3x	E17.8%	1.4%
KURN Kuros Biosciences	CHF 23.10	-0.2%	285.0%	CHF 876.1m	n/a	PS16.7x	n/a	n/a
COPN Cosmo Pharmaceuticals	CHF 66.50	3.4%	2.2%	CHF 1.1b	CHF 98.37	PE16.3x	E21.5%	2.8%
BSLN Basilea Pharmaceutica	CHF 44.85	11.3%	21.9%	CHF 544.0m	CHF 76.92	PE7x	E6.5%	0%
MOLN Molecular Partners	CHF 4.39	0.9%	10.6%	CHF 161.9m	CHF 9.75	PS27x	E-9.2%	n/a
SKAN SKAN Group	CHF 77.60	1.3%	-5.3%	CHF 1.7b	CHF 90.67	PE54.1x	E17.9%	0.5%
TECN Tecan Group	CHF 206.20	-4.4%	-42.6%	CHF 2.6b	CHF 271.67	PE26.1x	E12.9%	1.5%
NOVN Novartis	CHF 96.66	-1.1%	6.7%	CHF 190.9b	CHF 102.13	PE17.8x	E7.0%	3.6%
LONN Lonza Group	CHF 584.20	-2.3%	27.2%	CHF 42.2b	CHF 659.86	PE66.3x	E21.1%	0.7%
ADXN Addex Therapeutics	CHF 0.06	0.3%	-16.2%	CHF 5.9m	CHF 0.16	PS9.9x	E18.5%	n/a
DESN Dottikon ES Holding	CHF 212.00	-1.2%	-9.8%	CHF 2.9b	CHF 350.00	PE38.8x	S16.4%	0%
SANN Santhera Pharmaceuticals Holding	CHF 15.96	-7.1%	52.3%	CHF 201.0m	CHF 25.00	PE3.2x	S-76.7%	n/a
PPGN PolyPeptide Group	CHF 22.85	3.9%	39.4%	CHF 753.7m	CHF 36.16	PS2.5x	E64.9%	0%
GALD Galderma Group	CHF 113.76	-0.3%	n/a	CHF 27.0b	CHF 107.26	PS7x	E36.6%	n/a
ROG Roche Holding	CHF 295.30	-0.8%	29.0%	CHF 237.0b	CHF 309.37	PE28.4x	E14.6%	3.3%
SFZN Siegfried Holding	CHF 984.00	-8.0%	10.9%	CHF 4.3b	CHF 1,162.25	PE26.8x	E10.5%	0.4%
RLF Relief Therapeutics Holding	CHF 3.12	-9.6%	93.8%	CHF 39.1m	n/a	PS6.5x	n/a	n/a

Page 1 of 1